Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.
Similar Posts
US, partners target North Korea with sanctions after satellite launch
Post Content Post Views: 137
Stocks making the biggest moves before the bell: Lowe’s, Dick’s, Best Buy, Kohl’s and more
These are the stocks posting the largest moves in premarket trading. Post Views: 147
Warning: FSFG is at high risk of cutting its dividend
Post Content Post Views: 136
Colombia proposed health reform could push costs up by $234 million next year
Post Content Post Views: 131
Pro Research: Wall Street takes a closer look at Cisco’s prospects
Post Content Post Views: 122
US clean energy tax credit market flourishes under Biden’s climate law
Post Content Post Views: 130